Biological response modifier Rx:Type:Pt:Cancer.XXX:Nom:

Preferred Label : Biological response modifier Rx:Type:Pt:Cancer.XXX:Nom:;

LOINC status : ACTIVE;

LOINC long common name : Biological response modifier treatment Cancer;

LOINC short name : Biological response modifier Rx Cancer;

LOINC description : Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at this facility or the reason they were not given. Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to tumor cells. Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of immunotherapeutic agents as part of the first course of therapy.. NAACCR Data Standards and Data Dictionary Version 11;

Détails

Origin ID

21948-5;

UMLS CUI

C0804736;

Has component
- Biological response modifier Rx [LOINC component]
Has property
- Type [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Cancer [LOINC System]
- Cancer XXX [LOINC System]
- XXX [LOINC System]
- ^Cancer [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Treatment-1st course section:-:Pt:^Patient:Set:NAACCR v.11 [LOINC code]
- Treatment-1st course section:-:Pt:^Patient:Set:NAACCR v.12 [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients